Terms: = Endocrine gland cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4
93 results:
1. Pancreatic index: A prognostic factor of upfront surgery for body or tail pancreatic ductal adenocarcinoma with vascular involvement-A retrospective study.
Qian L; Li J; Sun Y; Chai W; Deng X; Wang W; Shen B
Cancer Med; 2023 Dec; 12(23):21199-21208. PubMed ID: 37933476
[TBL] [Abstract] [Full Text] [Related]
2. Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma.
Hedegger K; Blutke A; Hommel T; Auer KE; Nataraj NB; Lindzen M; Yarden Y; Dahlhoff M
Mol Oncol; 2023 Nov; 17(11):2415-2431. PubMed ID: 37341059
[TBL] [Abstract] [Full Text] [Related]
3. Prediction of EVT6-NTRK3-Dependent Papillary Thyroid cancer Using Minor Expression Profile.
Kechin AA; Ivanov AA; Kel AE; Kalmykov AS; Oskorbin IP; Boyarskikh UA; Kharpov EA; Bakharev SY; Oskina NA; Samuilenkova OV; Vikhlyanov IV; Kushlinskii NE; Filipenko ML
Bull Exp Biol Med; 2022 Jun; 173(2):252-256. PubMed ID: 35737155
[TBL] [Abstract] [Full Text] [Related]
4. High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival and strong anti-tumor immunity.
Karamitopoulou E; Andreou A; Wenning AS; Gloor B; Perren A
Eur J Cancer; 2022 Jul; 169():64-73. PubMed ID: 35512587
[TBL] [Abstract] [Full Text] [Related]
5. miR-551b is Associated with the Poor Prognosis and Malignant Development of Papillary Thyroid cancer Through Regulating erbb4.
Wang J; Liu H
Horm Metab Res; 2022 Feb; 54(2):113-118. PubMed ID: 35130572
[TBL] [Abstract] [Full Text] [Related]
6. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks.
Gulfidan G; Soylu M; Demirel D; Erdonmez HBC; Beklen H; Ozbek Sarica P; Arga KY; Turanli B
Arch Biochem Biophys; 2022 Jan; 715():109085. PubMed ID: 34800440
[TBL] [Abstract] [Full Text] [Related]
7. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/erbb4/PI3K/AKT axis.
Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
[TBL] [Abstract] [Full Text] [Related]
8. Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size.
Zhang X; Chen W; Fang Q; Fan J; Feng L; Guo L; Liu S; Ge H; Du W
Front Endocrinol (Lausanne); 2021; 12():716082. PubMed ID: 34335480
[TBL] [Abstract] [Full Text] [Related]
9. Improving Gemcitabine Sensitivity in Pancreatic cancer Cells by Restoring miRNA-217 Levels.
Panebianco C; Trivieri N; Villani A; Terracciano F; Latiano TP; Potenza A; Perri F; Binda E; Pazienza V
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33925948
[TBL] [Abstract] [Full Text] [Related]
10. Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer.
Khan T; Seddon AM; Dalgleish AG; Khelwatty S; Ioannou N; Mudan S; Modjtahedi H
Oncol Rep; 2020 Dec; 44(6):2581-2594. PubMed ID: 33125153
[TBL] [Abstract] [Full Text] [Related]
11. Combined Poziotinib with Manidipine Treatment Suppresses Ovarian cancer Stem-Cell Proliferation and Stemness.
Lee H; Kim JW; Lee DS; Min SH
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036254
[TBL] [Abstract] [Full Text] [Related]
12. Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice.
Hedegger K; Algül H; Lesina M; Blutke A; Schmid RM; Schneider MR; Dahlhoff M
Mol Oncol; 2020 Aug; 14(8):1653-1669. PubMed ID: 32335999
[TBL] [Abstract] [Full Text] [Related]
13. miR-326 inhibits the progression of papillary thyroid carcinoma by targeting MAPK1 and erbb4.
Nie FR; Li QX; Wei HF; Ma Y
Neoplasma; 2020 May; 67(3):604-613. PubMed ID: 32266816
[TBL] [Abstract] [Full Text] [Related]
14. Poziotinib suppresses ovarian cancer stem cell growth via inhibition of her4-mediated STAT5 pathway.
Lee H; Kim JW; Choi DK; Yu JH; Kim JH; Lee DS; Min SH
Biochem Biophys Res Commun; 2020 May; 526(1):158-164. PubMed ID: 32201081
[TBL] [Abstract] [Full Text] [Related]
15. Demcizumab combined with paclitaxel for platinum-resistant ovarian, primary peritoneal, and fallopian tube cancer: The SIERRA open-label phase Ib trial.
Coleman RL; Handley KF; Burger R; Molin GZD; Stagg R; Sood AK; Moore KN
Gynecol Oncol; 2020 May; 157(2):386-391. PubMed ID: 32037195
[TBL] [Abstract] [Full Text] [Related]
16. Discrepancy in calculated and measured glomerular filtration rates in patients treated with PARP inhibitors.
Zibetti Dal Molin G; Westin SN; Msaouel P; Gomes LM; Dickens A; Coleman RL
Int J Gynecol Cancer; 2020 Jan; 30(1):89-93. PubMed ID: 31792084
[TBL] [Abstract] [Full Text] [Related]
17. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
[TBL] [Abstract] [Full Text] [Related]
18. Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves' disease patients: a retrospective matched cohort study.
You E; Mascarella MA; Al Jassim A; Forest VI; Hier MP; Tamilia M; Pusztaszeri M; Payne RJ
J Otolaryngol Head Neck Surg; 2019 Aug; 48(1):40. PubMed ID: 31462328
[TBL] [Abstract] [Full Text] [Related]
19. Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian cancer Risk.
Reid BM; Permuth JB; Chen YA; Fridley BL; Iversen ES; Chen Z; Jim H; Vierkant RA; Cunningham JM; Barnholtz-Sloan JS; Narod S; Risch H; Schildkraut JM; Goode EL; Monteiro AN; Sellers TA
Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1117-1126. PubMed ID: 30948450
[TBL] [Abstract] [Full Text] [Related]
20. Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian cancer Cell Lines.
Papp E; Hallberg D; Konecny GE; Bruhm DC; Adleff V; Noë M; Kagiampakis I; Palsgrove D; Conklin D; Kinose Y; White JR; Press MF; Drapkin R; Easwaran H; Baylin SB; Slamon D; Velculescu VE; Scharpf RB
Cell Rep; 2018 Nov; 25(9):2617-2633. PubMed ID: 30485824
[TBL] [Abstract] [Full Text] [Related]
[Next]
